photo

Somponpun, Suwit Jack PhD

Pilot Project PI
Emerging Investigator - Cardiovascular Health
Assistant Professor
Dept. of Anatomy, Biochemistry & Physiology
John A. Burns School of Medicine

808.692.1420
suwit@hawaii.edu




Research Overview

2010-2011 RMATRIX Collaboration Pilot Projects Program Awards

(Co-funded in Partnership with the RTRN Small Grant Awards Program)

Project Description

Title: Morphogenetic Mechanism of Embryonic six2 in Establishing Nephron Endowment
Principal Investigator: Suwit Jack Somponpun, PhD, Dept. of Anatomy, Biochemistry & Physiology, UH JABSOM
Collaborator: Susanne Nicholas, MD, PhD, Dept. of Medicine, Charles Drew University
RMATRIX HEALTH Initiative(s): Cardiovascular
RMATRIX Funding: $25,000
External Link: http://www3.jabsom.hawaii.edu/Grad_DRB/faculty/somponpun.html

Abstract

Morphogenetic Mechanism of Embryonic six2 in Establishing Nephron Endowment

Suboptimal kidney development resulting in an in-born deficit in nephron number can have lifelong consequences and is associated with a significant risk of cardiovascular-renal disease in later life, compared to those born with a typical nephron endowment. The long-term goal of the current proposal is to identify cellular mechanisms that drive successful nephron differentiation to achieve optimal nephron endowment. Specifically, we will explore the roles of the homeobox gene sine oculis 2 (six2), and determine whether six2 is involved in the establishment of nephron number during kidney organogenesis. Using an RNAi methodology, experiments are designed to determine whether inactivation of six2 transcription early in nephrogenesis results in a significant decrease in ureteric bud growth and, therefore, nephron number in an organotypic kidney explant culture. Further, using a mouse model of heritable renal hypoplasia that lacks sufficient expression of six2 during development (the Brachyrrhine (Br) mutant mouse), we will take a systematic approach to re-introduce six2 to kidney explants that are prepared from Br mice and determine if exogenous six2 stimulates branching of the ureteric buds leading to an enhanced nephron production. This proposal will take advantage of the Br mouse strain that displays haploinsufficiency of six2 gene expression and is the only working colony in the world. Taken together, these experiments will provide the fundamental insights that constitute the genetic basis of six2 in renal morphogenesis and specifically establish whether six2 directly determines nephron endowment in the developing kidney. Results from this study will also underscore the importance of six2 in possible nephron restoration approaches in the adult diseased kidney. RELEVANCE: The proposed research is oriented toward a significant translational topic, namely the establishment of nephron number in the developing kidney that pertains specifically to cardiovascular disease and chronic renal failure. Specifically, the current study is aimed at identifying morphogenetic mechanisms that drive successful nephron differentiation to achieve optimal nephron number in the developing kidney.

News
04 October 2019:
NIH Loan Repayment Applications Now Being Accepted

Applications are currently being accepted for the FY 2020 NIH Loan Repayment Program (LRP) until November 15, 2019.

For over three decades, the NI…

20 August 2019:
PMCID Training Module

An online training module has been developed with support from the RMATRIX and Ola HAWAII grants. This module, entitled PMCIDs: Tracking & Submitting …

12 April 2019:
UHCC/USC Postdoctoral Fellowships

Postdoctoral Fellowships
Multidisciplinary training in ethnic diversity and cancer disparities

Program

The University of Hawaii Cancer Center (…


View more news...


Seminars & Events
18 October 2018, 11:00am - 2:00pm:
Data Security & Privacy
06 September 2018, 11:30am - 1:00pm:
Ola HAWAII Forum - Brown Bag Session
18 April 2018, 8am:
ANNUAL BIOMEDICAL SCIENCES and HEALTH DISPARITIES SYMPOSIUM

View more seminars & events...

Supported by a grant from the National Institute on Minority Health and Health Disparities (U54MD007584), National Institutes of Health.